Epsilon Healthcare Innovation Fund II, LP — Form D/A
Epsilon Healthcare Innovation Fund II, LP of WASHINGTON, DC, a pooled investment fund, filed a Form D amendment with the SEC on 2025-10-31. The offering totals $50.0M, of which $17.6M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-10-31
- Form: D/A
- Accession: 0001948657-25-000003
- Industry: Pooled Investment Fund
- Exemptions: 3C.7, 06b, 3C
- Total offering: $50.0M
- Amount sold: $17.6M
- Remaining: $32.5M
- Minimum investment: $100K
- Investors: 27
- Date of first sale: 2022-12-01
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-465330
Issuer
- Name: Epsilon Healthcare Innovation Fund II, LP
- CIK: 0001948657
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1227 25TH STREET NW, WASHINGTON, DC, 20037
- Phone: 2026027213
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Gregory H Epstein | Director | WASHINGTON, DC |
| Steven B Epstein | Director | WASHINGTON, DC |
| Stevens Andrew Brady | Executive Officer | Washington, DC |
| Gregory H Epstein | Executive Officer | WASHINGTON, DC |
| Steven B Epstein | Executive Officer | WASHINGTON, DC |
Other filings by this issuer (3)
More